Effects of Insulin Resistance in Non-diabetic Acute Coronary Syndrome Patients
NCT ID: NCT06163768
Last Updated: 2023-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1 participants
INTERVENTIONAL
2023-12-31
2026-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
insulin
This is a prospective study, without intervention in the clinical treatment plan at the hospital
Insulin resistance
Steps to conduct testing and treatment according to the approved regimen at Ho Chi Minh City University of Medicine and Pharmacy Hospital. The researcher did not intervene in the treatment process.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Insulin resistance
Steps to conduct testing and treatment according to the approved regimen at Ho Chi Minh City University of Medicine and Pharmacy Hospital. The researcher did not intervene in the treatment process.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Patients \< 18 years old.
* History of heart disease or stroke
* Exclude diabetic subjects
* Exclude subjects at high risk of insulin resistance
* Researchers
* Have diabetes or have previously been diagnosed with diabetes.
* Patients \< 18 years old.
* The patient does not participate in follow-up examinations and does not follow up treatment at the medical facility.
* The patient died before reaching the hospital.
* Patients with severe medical diseases: cirrhosis, cancer, obstructive pulmonary disease chronic obstructive pulmonary disease, chronic heart failure, severe kidney failure.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Medicine and Pharmacy at Ho Chi Minh City
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nguyen Ngoc Minh Thu
University of Medicine and Pharmacy at Ho Chi Minh City
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical and Pharmaceutical University Hospital
Ho Chi Minh City, Five, Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Nguyen Ngoc Minh Thu
Identifier Type: -
Identifier Source: org_study_id